Answers are grounded in this paper and cite their sources.
Review reveals how quantitative pharmacology streamlines multidrug antituberculosis regimens, indicating potential to accelerate shorter and safer clinical treatments.
), while effective integration of these data through quantitative pharmacology tools has facilitated more rational decision-making in preclinical and clinical drug development. This new framework permits a much more extensive and efficient evaluation of the space of novel and repurposed multidrug regimens in tuberculosis with the expectation of accelerating the arrival of even shorter, safer, and more effective treatments in the clinic.
No takes yet. Share an insight, caveat, or question.
Geraint Davies (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: